Breaking News Bar
updated: 5/16/2014 9:05 AM

Abbott to spend $2.9B on Latin American drugmaker

hello
Success - Article sent! close
  • Libertyville Township-based Abbott Laboratories says it will spend about $2.9 billion to broaden its reach in Latin America with the acquisition of fellow drugmaker CFR Pharmaceuticals.

    Libertyville Township-based Abbott Laboratories says it will spend about $2.9 billion to broaden its reach in Latin America with the acquisition of fellow drugmaker CFR Pharmaceuticals.
    File photo

 
Associated Press

Libertyville Township-based Abbott Laboratories says it will spend about $2.9 billion to broaden its reach in Latin America with the acquisition of fellow drugmaker CFR Pharmaceuticals.

Abbott makes infant formula like Similac as well as medical devices and drugs. The company says this deal will expand its presence in several fast-growing markets, especially with branded generic drugs.

CFR Pharmaceuticals sells more than 1,000 products in 15 Latin American markets.

Abbott says it will buy the holding company that owns about 73 percent of CFR and then will conduct a cash tender offer for the remaining shares. The price tops $3 billion when counting about $430 million in debt.

Abbott will use cash to pay for it and expects to close the acquisition by the end of the third quarter.

Article Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.
    Winner - 2015 Best Website
    Illinois Press Association
    Illinois Press Association